Rachel Goodwin

Ottawa Hospital — Canada

Medicine · Health Sciences

26h-index2.9kcitations167works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(49), Pancreatic and Hepatic Oncology Research(40), Gastric Cancer Management and Outcomes(30), Colorectal Cancer Surgical Treatments(28), Colorectal and Anal Carcinomas(27)

Publications167 total

Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature review
Cancer Treatment Reviews·2026Open Access
First-line Treatment Selection for Advanced Unresectable Biliary Tract Cancer
Canadian oncology today.·2025Open Access
Surrogate Endpoints for Overall Survival in Advanced Hepatocelluar Carcinoma in the Era of Immunotherapy: A Trial Level Meta-Analysis
Liver Cancer·2025Open Access
787P Real-world outcomes of organ preservation approach in patients with locally advanced rectal cancer in Canada: Results from the CHORD Consortium
Annals of Oncology·2025
Implementing Person-Centered, Clinical, and Research Navigation in Rare Cancers: The Canadian Cholangiocarcinoma Collaborative (C3)
Current Oncology·2025Open Access
Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma
iScience·2025Open Access
Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis
Communications Biology·2025· 5 citedOpen Access
The Impact of Adjuvant Chemotherapy on Clinical Outcomes in Locally Advanced Rectal Cancer: A CHORD Consortium Analysis
Current Oncology·2025Open Access
Australasian Gastro-Intestinal Trials Group (AGITG) STOPNET: A randomized study of cessation of somatostatin analogues (SSA) after peptide receptor radionuclide therapy (PRRT) in mid, hind-gut, and pancreatic neuroendocrine tumours.
Journal of Clinical Oncology·2025
Zanidatamab monotherapy or combined with chemotherapy in HER2-expressing gastroesophageal adenocarcinoma: a phase 1 trial
Nature Communications·2025· 5 citedOpen Access
303MO Zanidatamab (Zani) + chemotherapy (Chemo) for patients (Pts) with HER2-expressing metastatic breast cancer (mBC): Final results of a phase I trial
ESMO Open·2025· 1 citedOpen Access
A Canadian algorithm for upper gastrointestinal cancer management
Frontiers in Oncology·2025Open Access
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer
npj Precision Oncology·2025· 1 citedOpen Access
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024
Current Oncology·2025· 1 citedOpen Access
Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use
Current Oncology·2025· 1 citedOpen Access
Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer Centres
Current Oncology·2025· 1 citedOpen Access
Impact of synchronous vs metachronous primary tumor resection on prognosis of BRAF-V600E mutant metastatic colorectal cancer (mCRC).
Journal of Clinical Oncology·2025· 1 cited
Nutritional Considerations in Celiac Disease
Current Pediatrics Reports·2025
Real-world evaluation of treatment patterns and clinical outcomes in patients with BRAF-V600E metastatic colorectal cancer (mCRC) in Canada
Cancer Treatment and Research Communications·2025· 1 citedOpen Access
Real-World Evaluation of Clinical Outcomes in Patients with Braf-V600e Metastatic Colorectal Cancer (Mcrc)
SSRN Electronic Journal·2025Open Access
page 1 of 9Next →

Frequent Co-authors

Michael M. Vickers(12), Patricia A. Tang(10), Derek J. Jonker(9), Dongsheng Tu(9), Timothy R. Asmis(9), Philippe L. Bédard(6), Winson Y. Cheung(6), Jennifer J. Knox(6), Daniel J. Renouf(5), John Hilton(5), Lesley Seymour(5), Soundouss Raissouni(5), Di Jiang(5), Erin Powell(5), Jonathan M. Loree(5), Ming‐Sound Tsao(5), Ralph Wong(4), Erika Hamilton(4), Do‐Youn Oh(4), Diana L. Hanna(4)